Search Results - "Halpin, Rita A"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Absorption, Metabolism, and Excretion of Etoricoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Healthy Male Volunteers by Rodrigues, A David, Halpin, Rita A, Geer, Leslie A, Cui, Donghui, Woolf, Eric J, Matthews, Catherine Z, Gottesdiener, Keith M, Larson, Patrick J, Lasseter, Kenneth C, Agrawal, Nancy G B

    Published in Drug metabolism and disposition (01-02-2003)
    “…[ 14 C]Etoricoxib (100 μCi/dose) was administered to six healthy male subjects (i.v., 25 mg; p.o., 100 mg). Following the i.v. dose, the plasma clearance was…”
    Get full text
    Journal Article
  2. 2

    Role of Human Liver Cytochrome P4503A in the Metabolism of Etoricoxib, a Novel Cyclooxygenase-2 Selective Inhibitor by KASSAHUN, Kelem, MCINTOSH, Ian S, SHOU, Magang, WALSH, Deborah J, RODEHEFFER, Carey, SLAUGHTER, Donald E, GEER, Leslie A, HALPIN, Rita A, AGRAWAL, Nancy, RODRIGUES, A. David

    Published in Drug metabolism and disposition (01-06-2001)
    “…Etoricoxib, a potent and selective cyclooxygenase-2 inhibitor, was shown to be metabolized via 6′-methylhydroxylation (M2 formation) when incubated with…”
    Get full text
    Journal Article
  3. 3
  4. 4

    METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS by SLAUGHTER, Donald, TAKENAGA, Norihiro, BAILLIE, Thomas A, PING LU, ASSANG, Carol, WALSH, Deborah J, ARISON, Byron H, DONGHUI CUI, HALPIN, Rita A, GEER, Leslie A, VYAS, Kamlesh P

    Published in Drug metabolism and disposition (01-11-2003)
    “…The metabolism of rofecoxib, a potent and selective inhibitor of cyclooxygenase-2, was examined in vitro using human liver subcellular fractions. The…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The Absorption, Distribution, Metabolism and Excretion of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Rats and Dogs by HALPIN, Rita A, GEER, Leslie A, ZHANG, Kanyin E, MARKS, Tina M, DEAN, Dennis C, JONES, Allen N, MELILLO, David, DOSS, George, VYAS, Kamlesh P

    Published in Drug metabolism and disposition (01-10-2000)
    “…Absorption, distribution, metabolism, and excretion studies were conducted in rats and dogs with rofecoxib (VIOXX, MK-0966), a potent and highly selective…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans by VYAS, K. P, HALPIN, R. A, ROGERS, J. D, GEER, L. A, ELLIS, J. D, LIU, L, HAIYUNG CHENG, CHAVEZ-ENG, C, MATUSZEWSKI, B. K, VARGA, S. L, GUIBLIN, A. R

    Published in Drug metabolism and disposition (2000)
    “…The absorption and disposition of rizatriptan (MK-0462, Maxalt(TM)), a selective 5-HT(1B/1D) receptor agonist used in the treatment of migraine headaches, was…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Metabolism and hepatotoxicity of the naturally occurring benzo[b]pyran precocene I by Halpin, R A, Vyas, K P, El-Naggar, S F, Jerina, D M

    Published in Chemico-biological interactions (01-01-1984)
    “…The in vitro metabolism of precocene I by liver microsomes from control and treated rats and the effects of precocene I on the function and histology of the…”
    Get more information
    Journal Article